Why the study?
Is serum cardiac troponin I (cTnI) a better biochemical marker than CK, CK-MB, or myoglobin for detecting minor myocardial damage produced by radiofrequency catheter ablation?
Is serum cardiac troponin I (cTnI) a better biochemical marker than CK, CK-MB, or myoglobin for detecting minor myocardial damage produced by radiofrequency catheter ablation?
Cardiac troponin I is a superior biochemical marker compared to CK, CK-MB, and myoglobin for detecting minor myocardial damage following radiofrequency catheter ablation.
cTnI outperforms other markers for post-ablation injury detection; supports preference but leaves open need for outcome validation.
Radiofrequency (RF) catheter ablation is the curative treatment of choice for many cardiac arrhythmias. After RF ablation there is always a small localized endomyocardial necrosis, necessary to abolish the arrhythmia. We designed this study to determine the serum concentrations of several cardiac markers in patients who underwent RF catheter ablation. The study shows a higher frequency of increase of serum cardiac troponin I (cTnI) than of creatine kinase (CK), the CK MB isoenzyme (CK-MB), or myoglobin. A pathological value of cTnI was found in 47 of 51 patients (92%) in the ablation group. The area under the ROC curve for cTnI was 0.9375, significantly higher than for the other biochemical markers (0.86, 0.76, and 0.75 for CK-MB, myoglobin, and CK, respectively), with P <0.05. We conclude that the serum concentration of cTnI is the best biochemical marker for detecting the minor myocardial damage produced by RF ablation.
No takes yet. Share an insight, caveat, or question.
Rey et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: